Recent Updates
Recently added Catalysts

ABCp, Usual Care

Phase 2

Low Back Pain | Unknown | Pain |Bone Biologics Corp|Last Updated: Aug 29, 2025

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

ACTIVE_CONTROLLED
Total Trials1
Total Enrollment240

FDA Designations

No designations recorded

Clinical trial landscape

ABCp, Usual Care · 1 trial · 1 indication

Phase 2 1
NCT05452876Alberta Back Care Pathway (ABCp)Low Back Pain
RECRUITING240 Analytics
PHASE2RECRUITING
Alberta Back Care Pathway (ABCp)
Low Back PainUnlock trial analytics

Study Endpoints

Primary Endpoints

Primary Care visits
Through study completion, an average of 30 months

Number of GP revisits for LBP

Secondary Endpoints

GP ordered LBP imaging
Through study completion, an average of 30 months
GP requested specialist consultations
Through study completion, an average of 30 months
Unlock Study Endpoints

Study Design & Arms

AllocationNON_RANDOMIZED
MaskingNONE
ModelPARALLEL
PurposeTREATMENT

Treatment Arms

ArmTypeDescription
ABCpEXPERIMENTALThe patient sees MD that follows ABCp, patient then enrolls in ABCp intervention based on MD's categorization of low back pain.
Usual CareACTIVE_COMPARATORThe patient receives "usual care" at the clinical site.

Interventions

NameTypeDescription
ABCpOTHERIntervention is a care pathway that helps primary care physicians categorize back pain patients with each category having preferred interventions.
Usual CareOTHERStandard of care treatment
Unlock Study Design Details

Eligibility Criteria

Age Range18 Years to N/A
SexALL
Healthy VolunteersYes
Study Sites1

Inclusion Criteria: * Licensed physicians in the Edmonton West Primary Care Network (EWPCN) and the Calgary Chronic Pain Centre (CPC) * Age ≥18 years; (no upper age limit) * English speaking and a resident of Alberta who have cognition and language sufficient to understand written information, and ...

Countries:Canada
Unlock Eligibility Criteria

Frequently asked questions about ABCp, Usual Care

What is ABCp used for?

ABCp, also known as the Alberta Back Care Pathway, is an investigational care pathway being studied for the management of low back pain. It is currently in Phase 2 clinical development and is being evaluated in a clinical trial in Canada.

Who is developing ABCp?

ABCp is being developed by Bone Biologics Corp, a company listed on the NASDAQ under the ticker symbol BBLG. The company is conducting a Phase 2 clinical trial of the Alberta Back Care Pathway for low back pain.

What phase is ABCp in?

ABCp is in Phase 2 clinical development. It is an investigational care pathway and has not been approved by regulatory authorities. The ongoing Phase 2 trial is actively recruiting participants in Canada.

What clinical trials is ABCp in?

ABCp is being studied in a single Phase 2 clinical trial registered as NCT05452876, titled "Alberta Back Care Pathway (ABCp)". This trial is actively recruiting 240 participants aged 18 years and older with low back pain in Canada.

Is ABCp the same as the Alberta Back Care Pathway?

Yes, ABCp is the same as the Alberta Back Care Pathway. The clinical trial NCT05452876 is titled "Alberta Back Care Pathway (ABCp)", confirming that ABCp is an abbreviation for the full name of the care pathway being studied.